Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Clinical trial NCT03525834 · COMPLETED
Trial details
- NCT number
- NCT03525834
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-09
- Primary completion
- 2020-09-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.